Quick Search

 

 


 

 

Result Summary for 99910/188

Result Summary
Protocol ID: 99910/188
Clinical Study ID: 99910/188
Official Title: Effects of Dopaminergic Agonist Treatment on Spinal Cord Excitability in Restless Legs Syndrome
Phase: Phase 2
Study Indications or Diseases:
  • Restless Legs Syndrome
Generic Name: ropinirole
Trade/Product Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.